Skip to content

Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study

Prospective, Comparative, Randomized Study of GVF Versus Cross-linked Polyethylene in Total Knee Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00289133
Enrollment
938
Registered
2006-02-09
Start date
2005-02-01
Completion date
2013-05-01
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Rheumatoid, Osteoarthritis, Knee

Keywords

Arthroplasty, Replacement, Knee

Brief summary

The purpose of this study is to evaluate long-term clinical and radiographic data between geometrically identical GVF and cross-linked polyethylene-bearing inserts in total knee arthroplasty.

Detailed description

In 1996, Gamma Vacuum Foil (GVF) polyethylene was introduced as the first polyethylene to be gamma irradiated and packaged in an inert environment. This polyethylene, with its patented process and packaging, continues to be the only barrier-packaged process that is impermeable to both Hydrogen (H2) and Oxygen (O2), and allows the polyethylene to recombine and cross-link in the package. Though the new moderately cross-linked polyethylene being evaluated in this protocol is comparable to GVF geometrically and mechanically, the P.F.C.® Sigma™ cross-linked polyethylene also has the added benefit of being completely oxidatively stable both on the shelf and in-vivo. The P.F.C. Sigma tibial tray component being assessed in this study is made of Cobalt Chrome (CoCr). The new CoCr tibial tray has the same design geometrically as the original titanium (Ti) tray, however, it features a highly polished top surface where it is joined to the polyethylene. This polished surface is designed to decrease the coefficient of friction between the polyethylene and the tray, thus minimizing backside wear. A comparative clinical study will be conducted to evaluate long-term clinical and radiographic data between geometrically identical cemented implants using GVF and crosslinked polyethylene tibial tray bearing inserts in Total Knee Arthroplasty (TKA) using the P.F.C. Sigma Total Knee System. Patients will be assigned to study treatment groups at random if they meet specific demographic and pathophysiologic criteria for cemented total knee arthroplasty. The anticipated duration of this investigation is a minimum six years, which includes a one-year enrollment phase. The specific aims of this study are as follows: 1. Examine whether crosslinked polyethylene performs as well, if not better, than GVF polyethylene through standard clinical evaluations. 2. Evaluate long-term survivorship rates. 3. Report complications/adverse events. 4. Report radiographic findings of geometrically identical implants.

Interventions

DEVICEtotal knee arthroplasty

Gamma Vacuum Foil polyethylene tibial insert

Sponsors

DePuy Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Osteoarthritis of the affected joint appropriate for Total Knee Arthroplasty. 2. Diagnosis of any of the following: rheumatoid or other inflammatory arthritis, post-traumatic arthritis, juvenile rheumatoid arthritis. 3. Radiographic evidence of sufficient sound bone stock to seat and support the prosthesis. 4. Subject requires a primary total knee replacement and is considered to be suitable for the specific knee prosthesis identified in protocol. 5. Subject has given consent to the transfer of his/her information to sponsor. 6. Subject will be compliant with requirements of protocol by returning for follow-up visits.

Exclusion criteria

1. History of recent/active joint sepsis. 2. Charcot neuropathy. 3. Psycho-social disorders that would limit rehabilitation. 4. Women who are pregnant or planning on being pregnant. 5. Greater than 80 years of age at the time of surgery. 6. Prior ipsilateral knee arthroplasty. 7. Metabolic disorders of calcified tissues, such as Paget's disease. 8. Severe diabetes mellitus that is not controlled by diet or oral agents. 9. Require joint replacement due to immunodeficiency syndromes. 10. Skeletal immaturity. 11. Avascular necrosis of the affected knee. 12. Chronic renal disease. 13. Subjects involved in medical-legal or worker's compensation claims.

Design outcomes

Primary

MeasureTime frameDescription
Survivorship (Revision of Any Component for Any Reason)5 yearsSurvival was estimated by Kaplan-Meier method. Kaplan Meier survivorship analysis estimates the proportion of a population that will survive past a certain time avoiding a certain event. In this study, the event is removal of any component for any reason, also known as revision for any reason. Survival estimates are provided when 40 devices are left still being followed.

Secondary

MeasureTime frameDescription
Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score2 yearWOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.
Radiographic Outcomes - Percentage of Knees With Femoral Radiolucencies (>2mm)Minimum 5 years, up to 7.6 years
American Knee Society Evaluation - Total Score2 yearAmerican Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.
Radiographic Outcomes - Percentage of Knees With Femoral Osteolysis (>2mm)Minimum 5 years, up to 7.6 years
Radiographic Outcomes - Percentage of Knees With Tibial Osteolysis (>2mm)Minimum 5 years, up to 7.6 years
Radiographic Outcomes - Percentage of Knees With Tibial Radiolucencies (>2mm)Minimum 5 years, up to 7.6 years

Countries

United States

Participant flow

Participants by arm

ArmCount
GVF Poly
Gamma Vacuum Foil polyethylene tibial insert total knee arthroplasty: Gamma Vacuum Foil polyethylene tibial insert
449
XLK Poly
Cross-linked polyethylene tibial insert total knee arthroplasty: cross-linked polyethylene tibial insert
477
Total926

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath510
Overall StudyLost to Follow-up92115
Overall StudyLost to Follow-up - Hurricane Katri7374
Overall StudyNon-study device implanted120
Overall StudyPhysician Decision4145
Overall StudyProtocol Violation3238
Overall StudyRevision86
Overall StudyWithdrawal by Subject910

Baseline characteristics

CharacteristicGVF PolyXLK PolyTotal
Age, Continuous66.3 years
STANDARD_DEVIATION 8.5
66.4 years
STANDARD_DEVIATION 8.5
66.3 years
STANDARD_DEVIATION 8.5
Region of Enrollment
United States
449 participants477 participants926 participants
Sex: Female, Male
Female
290 Participants308 Participants598 Participants
Sex: Female, Male
Male
159 Participants169 Participants328 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
146 / 461164 / 477
serious
Total, serious adverse events
16 / 46115 / 477

Outcome results

Primary

Survivorship (Revision of Any Component for Any Reason)

Survival was estimated by Kaplan-Meier method. Kaplan Meier survivorship analysis estimates the proportion of a population that will survive past a certain time avoiding a certain event. In this study, the event is removal of any component for any reason, also known as revision for any reason. Survival estimates are provided when 40 devices are left still being followed.

Time frame: 5 years

Population: Survivorship can only be calculated on knees (not participants as some study subjects had bilateral knees in the study) with post-operative follow-up. 35 knees were excluded due to post-operative follow-up not being available. 67 knees were excluded due to protocol violations.

ArmMeasureValue (NUMBER)
GVF PolySurvivorship (Revision of Any Component for Any Reason)96.8 percentage of knees
XLK PolySurvivorship (Revision of Any Component for Any Reason)98.1 percentage of knees
Secondary

American Knee Society Evaluation - Total Score

American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.

Time frame: 2 year

Population: The number of knees analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (MEAN)Dispersion
GVF PolyAmerican Knee Society Evaluation - Total Score94.7 scores on a scaleStandard Deviation 7.9
XLK PolyAmerican Knee Society Evaluation - Total Score93.5 scores on a scaleStandard Deviation 9.5
Secondary

American Knee Society Evaluation - Total Score

American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.

Time frame: Minimum 5 years, up to 7.6 years

Population: The number of knees analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (MEAN)Dispersion
GVF PolyAmerican Knee Society Evaluation - Total Score93.5 scores on a scaleStandard Deviation 9.2
XLK PolyAmerican Knee Society Evaluation - Total Score93.1 scores on a scaleStandard Deviation 8.5
Secondary

Radiographic Outcomes - Percentage of Knees With Femoral Osteolysis (>2mm)

Time frame: Minimum 5 years, up to 7.6 years

Population: The number of knees in which radiographs were analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (NUMBER)
GVF PolyRadiographic Outcomes - Percentage of Knees With Femoral Osteolysis (>2mm)0 percentage of knees
XLK PolyRadiographic Outcomes - Percentage of Knees With Femoral Osteolysis (>2mm)0 percentage of knees
Secondary

Radiographic Outcomes - Percentage of Knees With Femoral Radiolucencies (>2mm)

Time frame: Minimum 5 years, up to 7.6 years

Population: The number of knees analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (NUMBER)
GVF PolyRadiographic Outcomes - Percentage of Knees With Femoral Radiolucencies (>2mm)9.5 percentage of knees
XLK PolyRadiographic Outcomes - Percentage of Knees With Femoral Radiolucencies (>2mm)7.6 percentage of knees
Secondary

Radiographic Outcomes - Percentage of Knees With Tibial Osteolysis (>2mm)

Time frame: Minimum 5 years, up to 7.6 years

Population: The number of knees in which radiographs were analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (NUMBER)
GVF PolyRadiographic Outcomes - Percentage of Knees With Tibial Osteolysis (>2mm)2.0 percentage of knees
XLK PolyRadiographic Outcomes - Percentage of Knees With Tibial Osteolysis (>2mm)1.4 percentage of knees
Secondary

Radiographic Outcomes - Percentage of Knees With Tibial Radiolucencies (>2mm)

Time frame: Minimum 5 years, up to 7.6 years

Population: The number of knees in which the radiographs were analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (NUMBER)
GVF PolyRadiographic Outcomes - Percentage of Knees With Tibial Radiolucencies (>2mm)0 percentage of knees
XLK PolyRadiographic Outcomes - Percentage of Knees With Tibial Radiolucencies (>2mm)2.1 percentage of knees
Secondary

Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score

WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.

Time frame: Minimum 5 years, up to 7.6 years

Population: The number of knees analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (MEAN)Dispersion
GVF PolyWestern Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score11.0 scores (points) on a scaleStandard Deviation 14.1
XLK PolyWestern Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score9.8 scores (points) on a scaleStandard Deviation 13.2
Secondary

Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score

WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.

Time frame: 2 year

Population: The number of knees analyzed was the number available for analysis at this post-operative timepoint.

ArmMeasureValue (MEAN)Dispersion
GVF PolyWestern Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score10.2 scores (points) on a scaleStandard Deviation 13.4
XLK PolyWestern Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score11.5 scores (points) on a scaleStandard Deviation 15.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026